Transplant Diagnostics Market

Industry Outlook

Transplant diagnostics are an integral step in organ transplant procedures. Transplant diagnostics are performed to study organ donor and recipient compatibility, and these methods also play a critical role after the transplantation procedure. Performing diagnosis methods at every stage of the transplant procedure assists physicians and surgeons in safeguarding patients by controlling the risk of organ failure or transplant rejection. As the global incidence of chronic diseases is increasing, the number of cases of organ failure is also on the rise. This has consequently resulted in increased growth in the transplant diagnostics market. The growing number of organ donations has further led to additional growth in the global transplant diagnostics market.

A precise diagnosis is a prerequisite for deciding on medication in transplantation. It was only recently that the precision in defining the mechanism of transplant rejection increased. Such development was mainly driven by the introduction of new diagnostic tools such as solid-phase HLA antibody testing and C4d staining. However, the current empirically derived diagnostic criteria for biopsy assessment are prone to varied interpretations and therefore have limited accuracy. Furthermore, the previously employed platforms and approaches for the assessment and monitoring of alloantibodies were also subject to institutional variation. Such a previous lack of precision in diagnostic and interpretation methods has had an impact on patient management.

Additionally, the identification of allograft injury is also vital for increasing the longevity of the transplant. Cases of acute rejection that result from a variety of immune and non-immune reasons pose a major risk to organ acceptance. The last two decades have marked a growth in the discovery of new transcriptomic, proteomic, and genomic biomarkers in molecular diagnostics, offering evolved potential for personalized patient management. The field of transplant diagnostics is seeking new methodologies that will allow multiplexing to simultaneously identify multiple targets, therefore providing more precise biomarkers and a better understanding of transplant mechanisms.

Market Synopsis

Higher Preference for Molecular Assays Observed as a Global Trend

Non-molecular assays are currently the dominant technology segment in the global transplant diagnostics market in terms of revenue. An increasing preference for non-invasive molecular assays is observed, surpassing the demand for serological assays. Benefits such as greater accuracy and less risk of deviant test results contribute to this trend. Non-molecular assays represent conventional methods for transplant diagnostics and are employed worldwide for the detection of transplant rejection. Furthermore, these methods allow the practice of antibody-based histocompatibility, offering low-resolution typing. Non-molecular assays address challenges faced during molecule identification that are involved in the immune rejection of mismatched grafts. In the molecular assays segment, PCR-based molecular assays hold a prominent market share globally. Sequencing-based molecular assays, comprising Sanger sequencing and next-generation sequencing, are anticipated to progress at a considerable pace during the forecast period.

Large procedure rates contribute to the dominance of solid organ transplant diagnostics.

Based on the type of transplant, the global transplant diagnostics market is categorized into solid organ transplantation and stem cell transplantation. Between these, the solid organ transplantation segment is expected to contribute to the leading share in the global market. Factors facilitating the dominance of this segment include higher procedure rates for kidney, liver, and heart transplants; growing incidence of end-stage renal diseases and cardiac conditions; and rising demand for new organs for cancer treatment. Supportive reimbursements in developed countries for the treatment of end-stage diseases have also led to high market demand for solid organ transplantations. On the other hand, technological developments in the field of stem cell transplantation and increased application areas of the same will allow rapid growth of this segment.

Pre- and Post-Transplant Diagnosis spearhead the global market

Due to the higher rates of solid organ transplantation, the market share of pre- and post-transplant diagnosis is significantly high in the global market. The greater incidence of renal, liver and cardiac diseases has urged more and more patients to opt for transplants. Therefore, verification of histocompatibility before transplantation procedures and follow-up tests for reducing the risk of transplant rejection up to several years following transplantation have contributed to a higher share of these segments. Additionally, technological evolution in HLA typing has further increased the uptake of pre-transplant diagnostics globally. On the other hand, growing drug discovery initiatives and evolution in the field of stem cell transplantation have urged increasing demand for both molecular and non-molecular diagnostic methods in research applications.

Reagents and Consumables, Hospitals and Transplant Centers Have a Major Influence on Market Size

Based on the product types, the global transplant diagnostics market is segmented into instruments, reagents and consumables, and software. Among these, the reagents and consumables segment contributes to a larger revenue share globally. A higher consumption rate of these products across all applications and end-uses, along with greater replacement rates despite the lower cost, is the key attribute of this segment. Additionally, hospitals and transplant centers, research and academia, and pathophysiology laboratories are the prime usage areas cumulatively contributing to this market. Hospitals and transplant centers are anticipated to take a major revenue share in the global market. Higher patient footfall and greater post-transplant diagnosis processes being performed at these locations are attributed to the leading position of this segment. The pathophysiology laboratories segment will progress at an above-benchmark rate during the forecast period due to the increasing trend of outsourcing test procedures.

The United States leads the global transplant diagnostics market due to greater awareness and a supportive business environment.

North America dominated the global transplant diagnostics market in 2018. The dominance of North America is mainly driven by the increasing geriatric population, the growing incidence of chronic diseases leading to organ failure, and the high adoption of transplantation techniques. Furthermore, the reduction in the cost of gene sequencing and growing private and public funding for the evolution of diagnostic techniques are other key drivers defining the North American market. Additionally, increasing awareness programs for the patient population, rapidly evolving skills of healthcare professionals, and increasing incomes are facilitating the fast market growth of the Asia Pacific region. In this region, China and Japan shall be the key revenue holders through the forecast period.

Historical and Forecast Period

2016: Historical Year

2017: Base Year

2018-2026: Forecast Period

This research report presents the analysis of each considered segment for the period from 2016 to 2026, using 2017 as the base year for estimations. Compounded annual growth rates (CAGRs) for each segment are calculated for the forecast period from 2018 to 2026.

Report Scope by Segments

This report includes qualitative and quantitative information on the transplant diagnostics industry, mapped for the period from 2016 to 2026. Qualitative information about this market is presented in the form of an analysis of each market segment, including drivers, challenges, opportunities, and the competitive landscape. The global transplant diagnostics market is segmented in terms of technology, transplant type, application, usage area, and geography.

By Technology (2016–2026; US$ Mn)

• Molecular Assays
• PCR-based molecular assays
• Sequencing-Based Molecular Assays
• Sanger Sequencing
• Next-Generation Sequencing
• Non-molecular Assays
• Serological Assays
• Mixed Lymphocyte Culture (MLC) Testing

By Transplant Type (2016–2026; US$ Mn)

• solid organ transplantation
• Stem Cell Transplantation

By Application (2016–2026; US$ Mn)

• Pre-transplantation Diagnostics
• Post-transplantation Diagnostics
• Research

By Products (2016–2026; US$ Mn)

• Instruments
• Reagents and consumables
• Software

By usage area (2016–2026; US$ Mn),

• Hospitals and Transplant Centers
• Research and academia
• Pathophysiology Laboratories

Geography Segment (2016–2026; US$ Mn)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • South-east Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa

The research study also includes a profile of the major market players engaged in this industry. Such profiling is performed on the following companies based on parameters such as business overview, financial information, product portfolio, and key developments: Thermo Fisher Scientific, Inc., Abbott Laboratories, Inc., Bio-Rad Laboratories, Bio-Reference Laboratories, F. Hoffmann-La Roche Ltd., Immucor, Inc., Illumina, Inc., Qiagen N.V., Luminex Corporation, and Genome Diagnostics B.V.

Chapter 1. Preface
1.1. Report Description
1.1.1. Study Purpose
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Market Segmentation
1.3. Research Scope
1.4. Research Methodology
1.4.1. Phase I – Secondary Research
1.4.2. Phase II – Primary Research
1.4.3. Phase III – Expert Panel Review
1.4.4. Assumptions
1.5. Market Segmentation

Chapter 2. Executive Summary
2.1. Global Transplant Diagnostics Market Portraiture
2.2. Global Transplant Diagnostics Market, by Technology, 2017 (US$ Mn)
2.3. Global Transplant Diagnostics Market, by Transplant Type, 2017 (US$ Mn)
2.4. Global Transplant Diagnostics Market, by Application, 2017 (US$ Mn)
2.5. Global Transplant Diagnostics Market, by Product, 2017 (US$ Mn)
2.6. Global Transplant Diagnostics Market, by Usage Area, 2017 (US$ Mn)
2.7. Global Transplant Diagnostics Market, by Geography, 2017 (US$ Mn)

Chapter 3. Global Transplant Diagnostics Market: Dynamics and Future Outlook
3.1. Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography, 2017
3.6. Competitive Analysis: Global Transplant Diagnostics Market, by Key Players, 2017

Chapter 4. Global Transplant Diagnostics Market, by Technology, 2016-2026 (US$ Mn)
4.1. Overview
4.2. Molecular Assays
4.2.1. PCR Based Molecular Assays
4.2.2. Sequencing Based Molecular Assays
4.2.2.1. Sanger sequencing
4.2.2.2. Next generation sequencing
4.3. Non-molecular Assays
4.3.1. Serological Assays
4.3.2. Mixed Lymphocyte Culture (MLC) Testing

Chapter 5. Global Transplant Diagnostics Market, by Transplant Type, 2016-2026 (US$ Mn)
5.1. Overview
5.2. Solid Organ Transplantation
5.3. Stem Cell Transplantation

Chapter 6. Global Transplant Diagnostics Market, by Application, 2016-2026 (US$ Mn)
6.1. Overview
6.2. Pre-transplantation Diagnostics
6.3. Post-transplantation Diagnostics
6.4. Research

Chapter 7. Global Transplant Diagnostics Market, by Product, 2016-2026 (US$ Mn)
7.1. Overview
7.2. Instruments
7.3. Reagents and Consumables
7.4. Software

Chapter 8. Global Transplant Diagnostics Market, by Usage Area, 2016-2026 (US$ Mn)
8.1. Overview
8.2. Hospitals and Transplant Centers
8.3. Research and Academia
8.4. Pathophysiology Laboratories

Chapter 9. Global Transplant Diagnostics Market, by Geography, 2016 – 2026 (US$ Mn)
9.1. Overview
9.1.1. North America Transplant Diagnostics Market, 2016-2026 (US$ Mn)
9.1.2. North America Transplant Diagnostics Market, by Technology, 2016 – 2026 (US$ Mn)
9.1.3. North America Transplant Diagnostics Market, by Transplant Type, 2016 – 2026 (US$ Mn)
9.1.4. North America Transplant Diagnostics Market, by Application, 2016 – 2026 (US$ Mn)
9.1.5. North America Transplant Diagnostics Market, by Product, 2016 – 2026 (US$ Mn)
9.1.6. North America Transplant Diagnostics Market, by Usage Area, 2016 – 2026 (US$ Mn)
9.1.7. North America Transplant Diagnostics Market, by Country, 2016 – 2026 (US$ Mn)
9.1.7.1. U.S.
9.1.7.2. Canada
9.2. Europe Transplant Diagnostics Market, 2016 – 2026 (US$ Mn)
9.2.1. Europe Transplant Diagnostics Market, by Technology, 2016 – 2026 (US$ Mn)
9.2.2. Europe Transplant Diagnostics Market, by Transplant Type, 2016 – 2026 (US$ Mn)
9.2.3. Europe Transplant Diagnostics Market, by Application, 2016 – 2026 (US$ Mn)
9.2.4. Europe Transplant Diagnostics Market, by Product, 2016 – 2026 (US$ Mn)
9.2.5. Europe Transplant Diagnostics Market, by Usage Area, 2016 – 2026 (US$ Mn)
9.2.6. Europe Transplant Diagnostics Market, by Country/Region, 2016 – 2026 (US$ Mn)
9.2.6.1. U.K.
9.2.6.2. Germany
9.2.6.3. Rest of Europe
9.3. Asia Pacific Transplant Diagnostics Market, 2016 – 2026 (US$ Mn)
9.3.1. Asia Pacific Transplant Diagnostics Market, by Technology, 2016 – 2026 (US$ Mn)
9.3.2. Asia Pacific Transplant Diagnostics Market, by Transplant Type, 2016 – 2026 (US$ Mn)
9.3.3. Asia Pacific Transplant Diagnostics Market, by Application, 2016 – 2026 (US$ Mn)
9.3.4. Asia Pacific Transplant Diagnostics Market, by Product, 2016 – 2026 (US$ Mn)
9.3.5. Asia Pacific Transplant Diagnostics Market, by Usage Area, 2016 – 2026 (US$ Mn)
9.3.6. Asia Pacific Transplant Diagnostics Market, by Country/Region, 2016 – 2026 (US$ Mn)
9.3.6.1. China
9.3.6.2. Japan
9.3.6.3. Rest of Asia Pacific
9.4. Latin America Transplant Diagnostics Market, 2016 – 2026 (US$ Mn)
9.4.1. Latin America Transplant Diagnostics Market, by Technology, 2016 – 2026 (US$ Mn)
9.4.2. Latin America Transplant Diagnostics Market, by Transplant Type, 2016 – 2026 (US$ Mn)
9.4.3. Latin America Transplant Diagnostics Market, by Application, 2016 – 2026 (US$ Mn)
9.4.4. Latin America Transplant Diagnostics Market, by Product, 2016 – 2026 (US$ Mn)
9.4.5. Latin America Transplant Diagnostics Market, by Usage Area, 2016 – 2026 (US$ Mn)
9.4.6. Latin America Transplant Diagnostics Market, by Country/Region, 2016 – 2026 (US$ Mn)
9.4.6.1. Brazil
9.4.6.2. Mexico
9.4.6.3. Rest of Latin America
9.5. Middle East & Africa Transplant Diagnostics Market, 2016 – 2026 (US$ Mn)
9.5.1. Middle East & Africa Transplant Diagnostics Market, by Technology, 2016 – 2026 (US$ Mn)
9.5.2. Middle East & Africa Transplant Diagnostics Market, by Transplant Type, 2016 – 2026 (US$ Mn)
9.5.3. Middle East & Africa Transplant Diagnostics Market, by Application, 2016 – 2026 (US$ Mn)
9.5.4. Middle East & Africa Transplant Diagnostics Market, by Product, 2016 – 2026 (US$ Mn)
9.5.5. Middle East & Africa Transplant Diagnostics Market, by Usage Area, 2016 – 2026 (US$ Mn)
9.5.6. Middle East & Africa Transplant Diagnostics Market, by Region, 2016 – 2026 (US$ Mn)
9.5.6.1. GCC
9.5.6.2. Rest of Middle East & Africa

Chapter 10. Company Profiles
10.1. Thermo Fisher Scientific, Inc.
10.1.1. Business Description
10.1.2. Financial Information (Subject to Data Availability)
10.1.3. Product Portfolio
10.1.4. Key Developments
10.2. Abbott Laboratories, Inc.
10.3. Bio-Rad Laboratories
10.4. Bio-Reference Laboratories
10.5. F. Hoffmann-La Roche Ltd.
10.6. Immucor, Inc.
10.7. Illumina, Inc.
10.8. Qiagen N.V.
10.9. Luminex Corporation
10.10. Genome Diagnostics B.V.

List of Figures

FIG 1. Transplant Diagnostics Market: Research Methodology
FIG 2. Transplant Diagnostics: Market Segmentation
FIG 3. Global Transplant Diagnostics Market, by Technology, 2017 (US$ Mn)
FIG 4. Global Transplant Diagnostics Market, by Transplant Type, 2017 (US$ Mn)
FIG 5. Global Transplant Diagnostics Market, by Application, 2017 (US$ Mn)
FIG 6. Global Transplant Diagnostics Market, by Product, 2017 (US$ Mn)
FIG 7. Global Transplant Diagnostics Market, by Usage Area, 2017 (US$ Mn)
FIG 8. Global Transplant Diagnostics Market, by Geography, 2017 (US$ Mn)
FIG 9. Attractive Investment Proposition, by Geography, 2017
FIG 10. Competitive Analysis: Global Transplant Diagnostics Market, by Key Players, 2017
FIG 11. Global PCR Based Molecular Assays Market for Transplant Diagnostics, 2016-2026(US$ Mn)
FIG 12. Global Sequencing Based Molecular Assays for Transplant Diagnostics, 2016-2026 (US$ Mn)
FIG 13. Global Sanger Sequencing Market for Transplant Diagnostics, 2016-2026 (US$ Mn)
FIG 14. Global Next Generation Sequencing Market for Transplant Diagnostics, 2016-2026 (US$ Mn)
FIG 15. Global Serological Assays Market for Transplant Diagnostics, 2016-2026 (US$ Mn)
FIG 16. Global Mixed Lymphocyte Culture (MLC) Testing Market for Transplant Diagnostics, 2016-2026 (US$ Mn)
FIG 17. Global Solid Organ Transplantation Diagnostics Market, 2016-2026 (US$ Mn)
FIG 18. Global Stem Cell Transplantation Transplant Diagnostics Market, 2016-2026 (US$ Mn)
FIG 19. Global Transplant Diagnostics Instruments Market, 2016-2026 (US$ Mn)
FIG 20. Global Transplant Diagnostics Reagents and Consumables Market, 2016-2026 (US$ Mn)
FIG 21. Global Transplant Diagnostics Software Market, 2016-2026 (US$ Mn)
FIG 22. Global Pre-transplantation Diagnostics Market, 2016-2026 (US$ Mn)
FIG 23. Global Post-transplantation Diagnostics Market, 2016-2026 (US$ Mn)
FIG 24. Global Transplant Diagnostics Market for Hospitals and Transplant Centers, 2016-2026 (US$ Mn)
FIG 25. Global Transplant Diagnostics Market for Research and Academia, 2016-2026 (US$ Mn)
FIG 26. Global Transplant Diagnostics Market for Pathophysiology Laboratories, 2016-2026 (US$ Mn)
FIG 27. U.S. Transplant Diagnostics Market, 2016-2026 (US$ Mn)
FIG 28. Canada Transplant Diagnostics Market, 2016-2026 (US$ Mn)
FIG 29. U.K. Transplant Diagnostics Market, 2016-2026 (US$ Mn)
FIG 30. Germany Transplant Diagnostics Market, 2016-2026 (US$ Mn)
FIG 31. Rest of Europe Transplant Diagnostics Market, 2016-2026 (US$ Mn)
FIG 32. China Transplant Diagnostics Market, 2016-2026 (US$ Mn)
FIG 33. Japan Transplant Diagnostics Market, 2016-2026 (US$ Mn)
FIG 34. Rest of Asia Pacific Transplant Diagnostics Market, 2016-2026 (US$ Mn)
FIG 35. Brazil Transplant Diagnostics Market, 2016-2026 (US$ Mn)
FIG 36. Mexico Transplant Diagnostics Market, 2016-2026 (US$ Mn)
FIG 37. Rest of Latin America Transplant Diagnostics Market, 2016-2026 (US$ Mn)
FIG 38. GCC Transplant Diagnostics Market, 2016-2026 (US$ Mn)
FIG 39. Rest of Middle East and Africa Transplant Diagnostics Market, 2016-2026 (US$ Mn)

List of Tables

TABLE 1 Global Transplant Diagnostics Market Portraiture
TABLE 2 Global Transplant Diagnostics Market, by Technology, 2016 – 2026 (US$ Mn)
TABLE 3 Global Transplant Diagnostics Market, by Transplant Type, 2016 – 2026 (US$ Mn)
TABLE 4 Global Molecular Assays Based Transplant Diagnostics Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 5 Global Sequencing Based Molecular Assays Based Transplant Diagnostics Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 6 Global Non-molecular Assays Based Transplant Diagnostics Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 7 Global Transplant Diagnostics Market, by Application, 2016 – 2026 (US$ Mn)
TABLE 8 Global Transplant Diagnostics Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 9 Global Transplant Diagnostics Market, by Usage Area, 2016 – 2026 (US$ Mn)
TABLE 10 Global Transplant Diagnostics Market, by Geography, 2016 – 2026 (US$ Mn)
TABLE 11 North America Transplant Diagnostics Market, by Technology, 2016 – 2026 (US$ Mn)
TABLE 12 North America Transplant Diagnostics Market, by Transplant Type, 2016 – 2026 (US$ Mn)
TABLE 13 North America Transplant Diagnostics Market, by Application, 2016 – 2026 (US$ Mn)
TABLE 14 North America Transplant Diagnostics Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 15 North America Transplant Diagnostics Market, by Usage Area, 2016 – 2026 (US$ Mn)
TABLE 16 North America Transplant Diagnostics Market, by Country, 2016 – 2026 (US$ Mn)
TABLE 17 Europe Transplant Diagnostics Market, by Technology, 2016 – 2026 (US$ Mn)
TABLE 18 Europe Transplant Diagnostics Market, by Transplant Type, 2016 – 2026 (US$ Mn)
TABLE 19 Europe Transplant Diagnostics Market, by Application, 2016 – 2026 (US$ Mn)
TABLE 20 Europe Transplant Diagnostics Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 21 Europe Transplant Diagnostics Market, by Usage Area, 2016 – 2026 (US$ Mn)
TABLE 22 Europe Transplant Diagnostics Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 23 Asia Pacific Transplant Diagnostics Market, by Technology, 2016 – 2026 (US$ Mn)
TABLE 24 Asia Pacific Transplant Diagnostics Market, by Transplant Type, 2016 – 2026 (US$ Mn)
TABLE 25 Asia Pacific Transplant Diagnostics Market, by Application, 2016 – 2026 (US$ Mn)
TABLE 26 Asia Pacific Transplant Diagnostics Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 27 Asia Pacific Transplant Diagnostics Market, by Usage Area, 2016 – 2026 (US$ Mn)
TABLE 28 Asia Pacific Transplant Diagnostics Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 29 Latin America Transplant Diagnostics Market, by Technology, 2016 – 2026 (US$ Mn)
TABLE 30 Latin America Transplant Diagnostics Market, by Transplant Type, 2016 – 2026 (US$ Mn)
TABLE 31 Latin America Transplant Diagnostics Market, by Application, 2016 – 2026 (US$ Mn)
TABLE 32 Latin America Transplant Diagnostics Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 33 Latin America Transplant Diagnostics Market, by Usage Area, 2016 – 2026 (US$ Mn)
TABLE 34 Latin America Transplant Diagnostics Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 35 Middle East and Africa Transplant Diagnostics Market, by Technology, 2016 – 2026 (US$ Mn)
TABLE 36 Middle East and Africa Transplant Diagnostics Market, by Transplant Type, 2016 – 2026 (US$ Mn)
TABLE 37 Middle East and Africa Transplant Diagnostics Market, by Application, 2016 – 2026 (US$ Mn)
TABLE 38 Middle East and Africa Transplant Diagnostics Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 39 Middle East and Africa Transplant Diagnostics Market, by Usage Area, 2016 – 2026 (US$ Mn)
TABLE 40 Middle East and Africa Transplant Diagnostics Market, by Region, 2016 – 2026 (US$ Mn)
TABLE 41 Thermo Fisher Scientific, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 42 Abbott Laboratories, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 43 Bio-Rad Laboratories: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 44 Bio-Reference Laboratories: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 45 F. Hoffmann-La Roche Ltd.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 46 Immucor, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 47 Illumina, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 48 Qiagen N.V.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 49 Luminex Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 50 Genome Diagnostics B.V.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)